- Home
- EHI vs SMTI Comparison
EHI vs SMTI Comparison
Compare EHI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EHI | SMTI |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.6M | 186.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EHI | SMTI |
|---|---|---|
| Price | $6.43 | $22.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $41.00 |
| AVG Volume (30 Days) | ★ 44.5K | 37.0K |
| Earning Date | 01-01-0001 | 11-12-2025 |
| Dividend Yield | ★ 11.54% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,877,532.00 |
| Revenue This Year | N/A | $21.60 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 30.52 |
| 52 Week Low | $6.00 | $18.90 |
| 52 Week High | $7.75 | $38.68 |
Technical Indicators
Market Signals| Indicator | EHI | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 43.97 |
| Support Level | $6.37 | $22.60 |
| Resistance Level | $6.44 | $24.48 |
| Average True Range (ATR) | 0.05 | 1.04 |
| MACD | 0.01 | -0.12 |
| Stochastic Oscillator | 65.38 | 9.54 |
Price Performance
Historical ComparisonAbout EHI Western Asset Global High Income Fund Inc
Western Asset Global High Inc Fd Inc is a non-diversified, closed-end management investment company. Its investment objective is high current income and total return by investing in a world-wide portfolio of securities. The fund invests in various sectors such as Consumer Discretionary, Financials, Energy, Communication energy, Industrials, materials, and others.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.